1. ? §´§Ö§Ý:+86-755-26890807
    ? §ï§Ý§Ö§Ü§ä§â§à§ß§ß§í§Û:export@

    §±§â§Ö§Õ§ã§ä§à§ñ§ë§Ú§Ö §ã§à§Ò§í§ä§Ú§ñ: CACLP 2025, Hangzhou

    §¯§à§Ó§à§ã§ä§Ú
    §¥§à§Þ / §¯§à§Ó§à§ã§ä§Ú
    2023
    DATE
    01 - 16
    2023/01/16 §µ§Ó§Ñ§Ø§Ñ§Ö§Þ§í§Ö §Ü§Ý§Ú§Ö§ß§ä§í! §®§í §â§Ñ§Õ§í §á§â§Ú§Ô§Ý§Ñ§ã§Ú§ä§î §Ó§Ñ§ã §á§â§Ú§ß§ñ§ä§î §å§é§Ñ§ã§ä§Ú§Ö §Ó §á§â§Ö§Õ§ã§ä§à§ñ§ë§Ö§Û §Ó§í§ã§ä§Ñ§Ó§Ü§Ö Medlab Middle East 2023 §Ó §Ü§Ñ§é§Ö§ã§ä§Ó§Ö §ß§Ñ§ê§Ö§Ô§à §á§à§é§Ö§ä§ß§à§Ô§à §Ô§à§ã§ä§ñ.§®§í §ç§à§ä§Ö§Ý§Ú §Ò§í §ß§Ñ§á§â§Ñ§Ó§Ú§ä§î §Ó§Ñ§Þ §Ú §Ó§Ñ§ê§Ö§Û §Ü§à§Þ§Ñ§ß§Õ§Ö §ï§Ü§ã§Ü§Ý§ð§Ù§Ú§Ó§ß§à§Ö §á§â§Ú§Ô§Ý§Ñ§ê§Ö§ß§Ú§Ö §á§à§ã§Ö§ä§Ú§ä§î §ß§Ñ§ê §ã§ä§Ö§ß§Õ Z1.E39 §Ó§à §Ó§â§Ö§Þ§ñ §Ó§í§ã§ä§Ñ§Ó§Ü§Ú.§³§á§å§ã§ä§ñ §á§à§é§ä§Ú 3 §Ô§à§Õ§Ñ §Þ§í §â§Ñ§Õ§í §Ó§Ú§Õ§Ö§ä§î
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2023
    DATE
    01 - 11
    §£§í §Ú§ë§Ö§ä§Ö §Ò§í§ã§ä§â§í§Û §Ú §ß§Ñ§Õ§Ö§Ø§ß§í§Û §ã§á§à§ã§à§Ò §á§â§à§Û§ä§Ú §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§Ö §ß§Ñ COVID-19, §Ô§â§Ú§á§á §Ú §²§³§£?§¯§Ö §Ú§ë§Ú§ä§Ö §ß§Ú§é§Ö§Ô§à, §Ü§â§à§Þ§Ö §ß§Ñ§ê§Ö§Ô§à §ß§Ñ§Ò§à§â§Ñ §Õ§Ý§ñ §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó! §¯§Ñ§ê §ß§Ñ§Ò§à§â §Õ§Ý§ñ §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ §Ñ§ß§ä§Ú§Ô§Ö§ß§Ñ RSV §Ô§â§Ú§á§á§Ñ COVID-19 ¡ª §ï§ä§à §å§Õ§à§Ò§ß§í§Û §Ú §ä§à§é§ß§í§Û §ã§á§à§ã§à§Ò §à§Ò§ß§Ñ§â§å§Ø§Ú§ä§î §ß§Ñ§Ý§Ú§é§Ú§Ö COVID-19, §Ô§â§Ú§á§á§Ñ §Ú §â§Ö§ã§á§Ú§â§Ñ§ä§à§â§ß§à-§ã§Ú§ß§è§Ú§ä§Ú§Ñ§Ý§î§ß§à§Ô§à §Ó§Ú§â§å§ã§Ñ (§²§³§£) §Ó§ã§Ö§Ô§à §Ù§Ñ 15 §Þ§Ú§ß§å§ä.Wi
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2022
    DATE
    08 - 26
    §²§Ñ§Õ §á§à§Õ§Ö§Ý§Ú§ä§î§ã§ñ §ã §Ó§Ñ§Þ§Ú §ß§à§Ó§à§ã§ä§î§ð §à §ä§à§Þ, §é§ä§à §Ó§ã§Ö §á§â§à§Õ§å§Ü§ä§í Goldsite §ä§Ö§á§Ö§â§î §Ù§Ñ§â§Ö§Ô§Ú§ã§ä§â§Ú§â§à§Ó§Ñ§ß§í §Ó §¡§Ô§Ö§ß§ä§ã§ä§Ó§Ö §á§à §â§Ö§Ô§å§Ý§Ú§â§à§Ó§Ñ§ß§Ú§ð §Ý§Ö§Ü§Ñ§â§ã§ä§Ó§Ö§ß§ß§í§ç §ã§â§Ö§Õ§ã§ä§Ó §Ú §ä§à§Ó§Ñ§â§à§Ó §Þ§Ö§Õ§Ú§è§Ú§ß§ã§Ü§à§Ô§à §ß§Ñ§Ù§ß§Ñ§é§Ö§ß§Ú§ñ §³§à§Ö§Õ§Ú§ß§Ö§ß§ß§à§Ô§à §¬§à§â§à§Ý§Ö§Ó§ã§ä§Ó§Ñ (MHRA).#goldsite #mhra #unitedkingdom #uk #healthcare #ivd #ivdr #clinical #lab #§Ý§Ñ§Ò§à§â§Ñ§ä§à§â§Ú§Ú #§Ü§Ý§Ú§ß§Ú§Ü§Ú #§Ò§à§Ý§î§ß§Ú§è§Ñ #§Ù§Õ§à§â§à§Ó§î§Ö
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2022
    DATE
    07 - 13
    §±§à§Õ§Ó§Ñ§â§Ú§Ñ§ß§ä§í Omicron BA.4 §Ú BA.5 §ä§Ö§á§Ö§â§î §à§ä§Ó§Ö§ä§ã§ä§Ó§Ö§ß§ß§í §Ù§Ñ §â§à§ã§ä §Ù§Ñ§Ò§à§Ý§Ö§Ó§Ñ§Ö§Þ§à§ã§ä§Ú §Ó§à §Ó§ã§Ö§Þ §Þ§Ú§â§Ö.§¯§à§Ó§í§Ö §Ú§ã§ã§Ý§Ö§Õ§à§Ó§Ñ§ß§Ú§ñ §á§à§Ü§Ñ§Ù§í§Ó§Ñ§ð§ä, §é§ä§à BA.4 §Ú BA.5 §ß§Ñ §Õ§Ñ§ß§ß§í§Û §Þ§à§Þ§Ö§ß§ä §ñ§Ó§Ý§ñ§ð§ä§ã§ñ §ß§Ñ§Ú§Ò§à§Ý§Ö§Ö §á§Ö§â§Ö§Õ§Ñ§ð§ë§Ú§Þ§Ú§ã§ñ §Ó§Ñ§â§Ú§Ñ§ß§ä§Ñ§Þ§Ú.§¿§Ü§ã§á§Ö§â§ä§í §£§ã§Ö§Þ§Ú§â§ß§à§Û §à§â§Ô§Ñ§ß§Ú§Ù§Ñ§è§Ú§Ú §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ §á§â§Ú§Ù§ß§Ñ§Ý§Ú, §é§ä§à BA.4 §Ú BA.5 §á§â§à§Õ§à§Ý§Ø§Ñ§ð§ä §Ó§í§Ù§í§Ó§Ñ§ä§î §Ó§à§Ý§ß§å §Ù§Ñ§Ò§à§Ý§Ö§Ó§Ñ§Ö§Þ§à§ã§ä§Ú §Ú §Ô§à§ã§á§Ú§ä§Ñ§Ý§Ú§Ù§Ñ§è§Ú§Û.
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2022
    DATE
    06 - 20
    §¥§Ö§â§Ö§Ó§ñ§ß§ß§í§Ö §Õ§à§Þ§Ñ, §Ü§à§ä§à§â§í§Ö §Þ§à§Ø§ß§à §Ü§å§á§Ú§ä§î §Ó §¬§Ú§ä§Ñ§Ö, §Ó §¬§Ú§ä§Ñ§Ö.†Î£¬‡øÙÉúÎï(Goldsite Diagnostics Inc) ×÷žé65¼Ò«@ÅúµÄÉú®aÉÌÖ®Ò», Éú®aµÄSARS- §¯§¡§¢§°§² §¡§¯§´§ª§¤§¦§¯§¡ COV-2 (§¬§°§­§­§°§ª§¥§¯§°§¦ §©§°§­§°§´§°) (§¥§­§Á §³§¡§®§°§´§¦§³§´§ª§²§°§£§¡§¯§ª§Á)ƒÈ¿ìËÙ™zœyйڲ¡¶¾¸ÐȾ,¿É¿ìËÙÓÐЧµØÓÃì¶§±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§², §±§¸§².¼ºÔÚ¼Ò¼´¿É²Ù×÷£¬ŸoÐ茣˜IÈËÊ¿²Ù×÷£¬²»ÐèÒª¾ß‚äÑ}ësµÄátŒWÓ–¾š£¬¼´Ê¹ÊǃºÍ¯ºÍÀÏÈË,Ò²¿ÉÒÔ×ÔÐÐ’ñ˜Ó,¼È·½±ãÓÖ¿ÉÒÔ±ÜÃâ´óÒŽ
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2022
    DATE
    06 - 09
    §®§Ú§ß§Ú§ã§ä§Ö§â§ã§ä§Ó§à §Ù§Õ§â§Ñ§Ó§à§à§ç§â§Ñ§ß§Ö§ß§Ú§ñ §¯§à§Ó§à§Û §©§Ö§Ý§Ñ§ß§Õ§Ú§Ú §¡§à§ä§Ö§Ñ§â§à§Ñ §à§Õ§à§Ò§â§Ú§Ý§à §ß§Ñ§Ò§à§â §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó Goldsite SARS-CoV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à) §Õ§Ý§ñ §ã§Ñ§Þ§à§ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ, §é§ä§à §á§à§Ù§Ó§à§Ý§Ú§Ý§à Goldsite §ã§à§ã§ä§Ñ§Ó§Ú§ä§î §ã§á§Ú§ã§à§Ü §à§Õ§ß§à§Ô§à §Ú§Ù 18 §á§â§à§Ú§Ù§Ó§à§Õ§Ú§ä§Ö§Ý§Ö§Û, §à§Õ§à§Ò§â§Ö§ß§ß§í§ç §Õ§Ý§ñ §Ý§Ö§Ô§Ñ§Ý§î§ß§à§Ô§à §â§í§ß§Ü§Ñ §Ó §¯§à§Ó§Ñ§ñ §©§Ö§Ý§Ñ§ß§Õ§Ú§ñ, §Ü 10 §Ú§ð§ß§ñ 2022 §Ô. §¿§ä§à§ä §Ü§à§Þ§á§Ý§Ö§Ü§ä §á§â§Ö§Õ§ß§Ñ§Ù§ß§Ñ§é§Ö§ß §Õ§Ý§ñ §Ó§í§ñ§Ó§Ý§Ö§ß§Ú§ñ §ß§à§Ó§í§ç §Ü§à§â§à§ß§Ñ§Ó§Ú§â§å§ã§ß§í§ç §Ú§ß§æ§Ö§Ü§è§Ú§Û §Ó
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2022
    DATE
    05 - 25
    §£§à§ä §Ó§ã§Ö, §é§ä§à §Ó§Ñ§Þ §ß§å§Ø§ß§à §Ù§ß§Ñ§ä§î §à§Ò §à§ã§á§Ö §à§Ò§Ö§Ù§î§ñ§ß. §¹§ä§à §ï§ä§à §Ù§Ñ §Ò§à§Ý§Ö§Ù§ß§î? §°§ã§á§Ñ §à§Ò§Ö§Ù§î§ñ§ß ¡ª §ï§ä§à §Ù§Ñ§Ò§à§Ý§Ö§Ó§Ñ§ß§Ú§Ö, §Ó§í§Ù§í§Ó§Ñ§Ö§Þ§à§Ö §Ó§Ú§â§å§ã§à§Þ §ä§à§Ô§à §Ø§Ö §ã§Ö§Þ§Ö§Û§ã§ä§Ó§Ñ, §é§ä§à §Ú §à§ã§á§Ñ, §ß§à §à§ß§à §ß§Ö §ä§Ñ§Ü§à§Ö §ã§Ö§â§î§Ö§Ù§ß§à§Ö, §ç§à§ä§ñ §Þ§à§Ø§Ö§ä §Ò§í§ä§î §ã§Þ§Ö§â§ä§Ö§Ý§î§ß§í§Þ §Õ§Ý§ñ §Ý§ð§Õ§Ö§Û, §Ù§Ñ§â§Ñ§Ù§Ú§Ó§ê§Ú§ç§ã§ñ §ï§ä§à§Û §Ò§à§Ý§Ö§Ù§ß§î§ð.§£§Ú§â§å§ã §à§ã§á§í §à§Ò§Ö§Ù§î§ñ§ß §á§â§Ú§ß§Ñ§Õ§Ý§Ö§Ø§Ú§ä §Ü §â§à§Õ§å Orthopoxvirus §ã§Ö§Þ§Ö§Û§ã§ä§Ó§Ñ Poxviri.
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2022
    DATE
    04 - 29
    §£§í, §Õ§à§Ý§Ø§ß§à §Ò§í§ä§î, §ç§à§â§à§ê§à §Ù§ß§Ñ§Ü§à§Þ§í §ã §ß§Ñ§Ù§Ó§Ñ§ß§Ú§Ö§Þ COVID-19 §Ú§Ý§Ú §Ü§à§â§à§ß§Ñ§Ó§Ú§â§å§ã§Ñ §Ù§Ñ §á§à§ã§Ý§Ö§Õ§ß§Ú§Ö 2 §Ô§à§Õ§Ñ. §£§í §Ü§à§Ô§Õ§Ñ-§ß§Ú§Ò§å§Õ§î §ã§Ý§í§ê§Ñ§Ý§Ú §à ?§¶§Ý§å§â§à§ß§Ö?, §ï§ä§à §Ô§Ú§á§Ö§â§â§Ö§Ñ§Ý§Ú§ã§ä§Ú§é§ß§à§Ö §ß§Ñ§Ù§Ó§Ñ§ß§Ú§Ö §ß§Ñ §ã§Ñ§Þ§à§Þ §Õ§Ö§Ý§Ö §ñ§Ó§Ý§ñ§Ö§ä§ã§ñ §â§Ö§Ñ§Ý§î§ß§í§Þ, §Ú §à§ß§à §Õ§Ñ§ä§Ú§â§å§Ö§ä§ã§ñ §Õ§Ö§Ü§Ñ§Ò§â§Ö§Þ §á§â§à§ê§Ý§à§Ô§à §Ô§à§Õ§Ñ, §Ü§à§Ô§Õ§Ñ §Ú§Ù§â§Ñ§Ú§Ý§î§ä§ñ§ß§Ü§Ñ §Ò§í§Ý§Ñ §å §ß§Ñ§ã §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§â§à§Ó§Ñ§Ý§Ú §Ú §Ô§â§Ú§á§á, §Ú §Ü§à§â§à§ß§Ñ§Ó§Ú§â§å§ã.§ª§ä§Ñ§Ü, §¶§Ý§å§â§à§ß§Ñ §Ò§í§Ý§Ñ §Ú§Ù§à§Ò§â§Ö§ä§Ö§ß§Ñ, §é§ä§à§Ò§í
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2021
    DATE
    11 - 29
    Goldsite §©§Ñ§ñ§Ó§Ý§Ö§ß§Ú§Ö §à §Ó§Ñ§â§Ú§Ñ§ß§ä§Ñ§ç Omicron §à§ä§ß§à§ã§Ú§ä§Ö§Ý§î§ß§à §ß§Ñ§Ò§à§â§Ñ §Ñ§ß§ä§Ú§Ô§Ö§ß§à§Ó SARS-COV-2 (§Ü§à§Ý§Ý§à§Ú§Õ§ß§à§Ö §Ù§à§Ý§à§ä§à), §ã§á§à§ã§à§Ò§ß§à§ã§ä§Ú §à§Ò§ß§Ñ§â§å§Ø§Ú§Ó§Ñ§ä§î §ß§à§Ó§í§Ö §Ó§í§Ù§í§Ó§Ñ§ð§ë§Ú§Ö §Ò§Ö§ã§á§à§Ü§à§Û§ã§ä§Ó§à §Ó§Ñ§â§Ú§Ñ§ß§ä§í SARS-CoV-2. 29 §ß§à§ñ§Ò§â§ñ 2021 §Ô. §£ §ã§Ó§ñ§Ù§Ú §ã §á§Ñ§ß§Õ§Ö§Þ§Ú§é§Ö§ã§Ü§à§Û §Ó§ã§á§í§ê§Ü§à§Û COVID-19, §Þ§ß§à§Ø§Ö§ã§ä§Ó§Ö§ß§ß§í§Þ§Ú SARS-CoV -§±§à§ñ§Ó§Ú§Ý§à§ã§î 2 §Ó§Ñ§â§Ú§Ñ§ß§ä§Ñ §Ó§Ú§â§å§ã§Ñ, §Ó§Ü§Ý§ð§é§Ñ§ñ §Ý§Ú§ß§Ú§ð B.1.1.7 (§¡§Ý§î§æ§Ñ), B.1.351.
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö
    2021
    DATE
    11 - 13
    §¬§à§Þ§á§Ñ§ß§Ú§ñ Goldsite §ã§Ö§Ô§à§Õ§ß§ñ §à§Ò§ì§ñ§Ó§Ú§Ý§Ñ, §é§ä§à §á§à§Ý§å§é§Ú§Ý§Ñ §Ù§ß§Ñ§Ü CE §Ù§Ñ §ß§Ñ§Ù§Ñ§Ý§î§ß§í§Û §ã§Ñ§Þ§à§ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§Ö §ß§Ñ §Ñ§ß§ä§Ú§Ô§Ö§ß SARS-CoV-2 §Õ§Ý§ñ §Õ§à§Þ§Ñ§ê§ß§Ö§Ô§à §ä§Ö§ã§ä§Ú§â§à§Ó§Ñ§ß§Ú§ñ.§´§Ö§ã§ä §Ò§å§Õ§Ö§ä §Õ§à§ã§ä§å§á§Ö§ß §Ó §ã§ä§â§Ñ§ß§Ñ§ç, §á§â§Ú§ß§Ú§Þ§Ñ§ð§ë§Ú§ç §Ù§ß§Ñ§Ü CE, §Ó §Ñ§á§ä§Ö§Ü§Ñ§ç §Ú §Õ§â§å§Ô§Ú§ç §Þ§Ö§ã§ä§Ñ§ç §Ó §å§á§Ñ§Ü§à§Ó§Ü§Ñ§ç §á§à §á§ñ§ä§î §ä§Ö§ã§ä§à§Ó. §²§Ñ§ß§ß§ñ§ñ §Ó§Ö§â§ã§Ú§ñ §ä§Ö§ã§ä§Ñ §å§Ø§Ö §Õ§à§ã§ä§å§á§ß§Ñ §Ü§Ñ§Ü §Ñ§ç.
    §¹§Ú§ä§Ñ§ä§î §¥§Ñ§Ý§Ö§Ö

    §±§à§ã§Þ§à§ä§â§Ú§ä§Ö §á§à§ã§Ý§Ö§Õ§ß§Ú§Ö §ä§Ö§ß§Õ§Ö§ß§è§Ú§Ú Goldsite §Ó §ã§à§è§Ú§Ñ§Ý§î§ß§í§ç §ã§Ö§ä§ñ§ç.

    Goldsite Diagnostics Inc., §à§ã§ß§à§Ó§Ñ§ß§ß§Ñ§ñ §Ó 1999 §Ô§à§Õ§å, §ñ§Ó§Ý§ñ§Ö§ä§ã§ñ §Ó§Ö§Õ§å§ë§Ú§Þ §Ü§Ú§ä§Ñ§Û§ã§Ü§Ú§Þ §á§â§à§Ú§Ù§Ó§à§Õ§Ú§ä§Ö§Ý§Ö§Þ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§é§Ö§ã§Ü§Ú§ç §ã§â§Ö§Õ§ã§ä§Ó, §ã§á§Ö§è§Ú§Ñ§Ý§Ú§Ù§Ú§â§å§ð§ë§Ú§Þ§ã§ñ §ß§Ñ §å§ã§ä§â§à§Û§ã§ä§Ó§Ñ§ç §Ú §â§Ö§Ñ§Ô§Ö§ß§ä§Ñ§ç §Õ§Ý§ñ §Õ§Ú§Ñ§Ô§ß§à§ã§ä§Ú§Ü§Ú in vitro.

    §³§ã§í§Ý§Ü§Ú §ß§Ñ §á§â§à§Õ§å§Ü§ä§í

    §³§Ó§ñ§Ù§Ñ§ä§î§ã§ñ

    (+86)-755-26890807

        (+86)-755-26897973
    export@

     

    Copyright © 1999¨C2023 Goldsite Diagnostics Inc., §£§ã§Ö §á§â§Ñ§Ó§Ñ §Ù§Ñ§ë§Ú§ë§Ö§ß§í. Sitemap